High milk consumption raises mortality (women drinking 3+ glasses/day had 93% higher mortality) and increases rather than prevents hip fractures.

Original statement

وحين تتبّعت دراسة سويدية ضخمة نشرتها BMJ عام 2014 أكثر من مئة ألف رجل وامرأة لعقدين، وجدت أن النساء اللواتي يشربن ثلاثة أكواب أو أكثر يوميًا كان لديهن خطر وفاة أعلى بنسبة 93٪، وزادت كسور الورك بدلًا من أن تنقص.

not verbatim – paraphrase. Translation by the project; the Arabic wording is authoritative.

Translation

High milk consumption raises mortality (women drinking 3+ glasses/day had 93% higher mortality) and increases rather than prevents hip fractures.

Origin

Source status

Archive editors

Attribution

Archive editors (eltayebat.com, rule 'dairy')

Origin

https://eltayebat.com/rule/dairy/

Attribution uncertainty

Editorial narrative and study selection by the archive operators, not shown to be Elawady's own words; the archive homepage says the forbidden section is documented 'independently of Dr. Diaa's words'.

Claimed mechanism

Oxidative stress and inflammation (D-galactose hypothesis cited by the study authors; archive mentions 'markers of oxidative stress and inflammation').

Claimed health effect

Higher all-cause mortality and more hip fractures.

Population concerned

Adults, especially women.

Geographic restriction by Elawady

none found

Scientific assessment

Potentially false – The available evidence tends to speak against the statement, but is not conclusive.

Certainty of evidence: low – Further research is likely to change the assessment considerably.

1. What was claimed?

Drinking a lot of milk shortens life and increases hip fractures.

2. What is demonstrably correct?

A-DRY-01 reported HR 1.93 (95% CI 1.80-2.06) for mortality in women drinking >=3 vs <1 glass/day and HR 1.09 (1.05-1.13) per glass for hip fracture in women; the archive reproduces these figures correctly. In absolute terms, women's all-cause mortality was 17.7 vs 10.7 and hip-fracture rates 4.2 vs 3.1 per 1,000 person-years (>=3 vs <1 glass/day) (A-DRY-01). In US cohorts, the highest dairy category (about 4.2 servings/day) had a slightly higher mortality (HR 1.07, 1.04-1.10), and whole milk was associated with higher mortality (I-DRY-01). The archive is also partly right on fractures: no meta-analysis reviewed shows that milk prevents hip fracture, a cohort dose-response analysis found a non-linear rise in risk from 0 to 600 g/day (I-DRY-03), and one meta-analysis in an umbrella review reported RR 1.09 (1.07-1.11) per 200 g/day (with publication bias; I-DRY-12).

3. What is wrong or exaggerated?

The archive omits the authors' own warning: 'a cautious interpretation of the results is recommended' because of residual confounding and reverse causation. In the male cohort the per-glass mortality HR was only 1.03 and there was no fracture association; in women, analyses using a single baseline measure gave attenuated estimates similar to those in men, so the 93% figure depends on the analysis method (A-DRY-01). Meta-analyses do not confirm a general mortality harm: total dairy and milk were neutral for mortality and CVD in 29 cohorts (I-DRY-02), and all-cause mortality was null in the umbrella review (RR 0.99, 0.98-1.00; I-DRY-12). For hip fracture, highest-versus-lowest milk intake was not associated with risk in cohorts (RR 0.91, 0.74-1.12; I-DRY-03; 0.93, 0.75-1.15 in I-DRY-12), so 'increases' is not established either. The 93% figure is a relative comparison of extreme groups in one cohort, not a general effect of dairy.

4. What remains unclear?

Whether very high intakes (>3 glasses/day) carry some risk; whether the small positive dose-response signals for hip fracture are real; why Swedish results differ from others.

5. Which studies support it?

A-DRY-01; partly I-DRY-01 (small excess at the highest intake, whole milk); partly I-DRY-03 and I-DRY-12 (positive dose-response signals for hip fracture, low certainty).

6. Which studies contradict it?

I-DRY-02 (neutral for mortality and CVD); I-DRY-12 (null all-cause mortality, null high-vs-low hip fracture); I-DRY-03 (null high-vs-low and linear dose-response for hip fracture).

7. What applies to Germany and Europe?

Results from Sweden are European but intake levels (several glasses daily) are higher than in many countries.

8. What is known about Egypt?

No Egyptian cohort data found.

9. What practical conclusion is appropriate?

Very high milk intakes are not needed for bone health, but the evidence does not show that moderate dairy intake raises mortality or fractures.

Assessment details

Rationale for certainty of evidence

The numbers come from one well-conducted observational cohort and are reported correctly, but the 93% mortality figure depends on the time-updated analysis (single-exposure analyses in women gave much smaller estimates, similar to men) and is not replicated: meta-analyses of cohorts show neutral associations of milk with mortality. For hip fracture the evidence is inconsistent rather than reassuring: high-versus-low comparisons are null, but some dose-response analyses show a small positive association. Observational data only; confounding possible.

Source quality

Archive editorial; numbers match the study abstract.

Regional transferability

Scandinavian populations with very high milk intakes; transfer to Egypt (lower intakes, different dairy types) is uncertain.

Individual exceptions

None specific.

Regional scope of the claim

general (biological/medical)

Last reviewed

25 October 2026 provisional

In plain language

A large Swedish study found that women who drank three or more glasses of milk a day died earlier and did not have fewer hip fractures. The archive reports these figures correctly, but leaves out that the researchers themselves asked for caution, and the large difference shrank with a simpler analysis. When many studies are combined, milk looks neutral for mortality. For hip fractures the picture is mixed: milk does not seem to protect, and some analyses suggest a small increase at higher intakes. So the Swedish result is a warning signal for very high intakes, not proof that dairy is harmful.

Studies on this claim

Regional context

Germany / EU

Results from Sweden are European but intake levels (several glasses daily) are higher than in many countries.

Egypt

No Egyptian cohort data found.

• Antimicrobial use in food animals and antibiotic growth promoters
• Hormones in poultry, meat, milk and farmed fish
• Dioxins, PCBs and PFAS in eggs and other animal foods
• Aflatoxin M1 in milk and dairy products
• Import controls and the meaning of RASFF notifications for Egyptian products

What applies in my country?

General scientific assessment

Potentially false One Swedish cohort found higher mortality with very high milk intake, but the total evidence does not show that dairy increases mortality; milk also does not appear to prevent hip fractures, and a small increase is possible but unproven.

The following areas of food safety are relevant to this statement:

• Veterinary medicines and antibiotics
• Hormonal growth promoters
• Contaminants (heavy metals, PFAS, PCBs, dioxins, nitrate)
• Mycotoxins (mould toxins)
• Controls, imports, recalls, labelling

Dairy

Limits: legal rules describe what is allowed, not what every single food contains. Measurement data come from samples and are meaningful only together with their method details.

Country of residence or purchase Compare with another country

References

1. Milk intake and risk of mortality and fractures in women and men: cohort studies.. Michaëlsson K et al.. BMJ 2014 · PMID 25352269 · DOI 10.1136/bmj.g6015
2. Milk and dairy consumption and risk of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies.. Guo J et al.. Eur J Epidemiol 2017 · PMID 28374228 · DOI 10.1007/s10654-017-0243-1
3. Associations of dairy intake with risk of mortality in women and men: three prospective cohort studies.. Ding M et al.. BMJ 2019 · PMID 31776125 · DOI 10.1136/bmj.l6204
4. Milk consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses in humans.. Zhang X et al.. Nutr Metab (Lond) 2021 · PMID 33413488 · DOI 10.1186/s12986-020-00527-y
5. Dairy product consumption and risk of hip fracture: a systematic review and meta-analysis.. Bian S et al.. BMC Public Health 2018 · PMID 29357845 · DOI 10.1186/s12889-018-5041-5